| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |